icone plus
Contact
Abonnez-vous aux actualités
Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
Moderate
The actual benefit of AETOXISCLEROL is moderate.
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
AZtV88TMnspjBGMP